Feasibility and safety of norepinephrine-induced arterial hypertension in acute ischemic stroke
Abstract
The feasibility and safety of induced arterial hypertension (10 to 20% of the initial value) in the acute phase of ischemic stroke were retrospectively evaluated in 34 patients treated with norepinephrine (NE) for a median of 26 hours. Maximal variability of systolic blood pressure during NE application was within 15% of the target values. Cardiac arrhythmia occurred in one patient, and intracerebral hemorrhage occurred in two patients (fatal in one and asymptomatic in the other). The authors conclude that induced arterial hypertension is feasible and safe in patients with acute stroke.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug induced hypertension for treatment of acute stroke. Neurology. 2001; 56: 1210–1213.
2.
Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke. 2002; 33: 998–1004.
3.
Baumgartner RW, Sidler C, Mosso M, Georgiadis D. Lacunar stroke due to small artery disease or other potential causes. Stroke. 2003; 34: 653–659.
4.
Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35–41.
5.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333: 1581–1587.
6.
Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352: 1245–1251.
7.
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. JAMA. 1999; 282: 2019–2026.
8.
Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno FS, Koroshetz WJ. Pharmacological elevation of blood pressure in acute stroke: clinical effects and safety. Stroke. 1997; 28: 2133–2138.
Information & Authors
Information
Published In
Copyright
© 2004.
Publication History
Received: July 11, 2003
Accepted: December 10, 2003
Published online: April 12, 2004
Published in print: April 13, 2004
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Assessing Practice Variation of Anesthetic Management for Endovascular Thrombectomy in Acute Ischemic Stroke: A Comprehensive Multicenter Survey, Journal of Neurosurgical Anesthesiology, (2024).https://doi.org/10.1097/ANA.0000000000000976
- Drug-induced arterial hypertension in a patient with ischemic stroke, Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH), 13, 4, (127-133), (2023).https://doi.org/10.20340/vmi-rvz.2023.4.CASE.4
- Review of Cerebral Collateral Circulation and Insight into Cardiovascular Strategies to Limit Collateral Damage in Ischemic Stroke, Cardiology in Review, 32, 3, (188-193), (2023).https://doi.org/10.1097/CRD.0000000000000614
- Pressor therapy in acute ischaemic stroke: an updated systematic review, European Stroke Journal, 7, 2, (99-116), (2022).https://doi.org/10.1177/23969873221078136
- Predicting prognosis in patients with stroke treated with intravenous alteplase through the 24‐h trajectory of blood pressure changes, The Journal of Clinical Hypertension, 23, 9, (1718-1730), (2021).https://doi.org/10.1111/jch.14331
- Blood Pressure Management Before, During, and After Endovascular Thrombectomy for Acute Ischemic Stroke, Seminars in Neurology, 41, 01, (046-053), (2021).https://doi.org/10.1055/s-0040-1722721
- Pharmacologically Induced Hypertension Therapy for Acute Stroke Patients, Journal of Stroke, 21, 2, (228-230), (2019).https://doi.org/10.5853/jos.2019.00437
- Therapeutic-induced hypertension in patients with noncardioembolic acute stroke, Neurology, 93, 21, (e1955-e1963), (2019)./doi/10.1212/WNL.0000000000008520
- Management of Acute Ischemic Stroke and its Late Complications, Textbook of Stroke Medicine, (376-394), (2019).https://doi.org/10.1017/9781108659574.023
- Central Noradrenergic Agonists in the Treatment of Ischemic Stroke—an Overview, Translational Stroke Research, 11, 2, (165-184), (2019).https://doi.org/10.1007/s12975-019-00718-7
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.